The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana merger earlier this fall.

KEY TAKEAWAYS Humana shares are tumbling Monday morning after The Cigna Group said it is not pursuing a merger with its smaller health insurance rival.Negotiations by Cigna to buy Human fell apart ...

Cigna said it isn't seeking to buy Humana, bolstering its stock and weighing on the share price of the Medicare-focused company. Cigna spoke out because of ongoing speculation it would strike a deal ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...

“Humana is a good carrier to keep in mind for prescription benefits, especially with some hard-to-cover drugs,” says Freitag. Please contact Medicare.gov, 1-800-MEDICARE, or your local State ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

Joe Buglewicz / Bloomberg via Getty Images Discussions over Cigna's possible purchase of Humana reportedly have resumed after the two health insurers failed to strike a deal last year. Bloomberg ...

Shares of Humana Inc. rallied Monday, and Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — it’s just a matter of timing. Hynes’ comment was in response to a ...

The health insurer posted revenue of $29.4 billion in the period. Its adjusted revenue was $29.3 billion, also topping Street forecasts. Six analysts surveyed by Zacks expected $28.66 billion. Humana ...

Humana (NYSE:HUM) increased its annual membership guidance for its Medicare Advantage business with its Q3 2024 financials on Wednesday despite facing a series of setbacks for the segment this ...

Based on this news, shares of Humana fell by more than 20.5%. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall ...